[ Price : $8.95]
FDA issues a draft guidance detailing expectations for how makers of cuffless, non-invasive blood pressure monitoring devices shou...[ Price : $8.95]
FDA releases the form FDA-483 with six observations from an inspection at the Lupin sterile manufacturing facility in Nagpur, Indi...[ Price : $8.95]
Cogent Biosciences says FDA has agreed to accept the companys planned NDA for cancer drug bezuclastinib under the agencys Real-Tim...[ Price : $8.95]
FDA says it will start accepting applications on 2/1 for its new PreCheck Pilot program intended to boost domestic drug manufactur...[ Price : $8.95]
Four drug industry stakeholders say they support an FDA draft guidance proposing to reduce reliance on comparative efficacy studie...[ Price : $8.95]
FDA commissioner Marty Makary discusses upcoming actions to encourage more prescription-to-over-the-counter drug switches.[ Price : $8.95]
IntraBio reports positive results from a pivotal Phase 3 clinical trial showing that levacetylleucine significantly improved neuro...[ Price : $8.95]
FDA says its new ImportShield program improved processing speed and volume capacity while reducing staff hours in its first four m...